University of Maryland researchers notch second retraction

jbc 42514Two researchers at the University of Maryland who retracted a paper earlier this year for a duplicated figure have withdrawn another, this time for unknown reasons.

The Journal of Biological Chemistry (JBC) paper has been cited 16 times, according to Thomson Scientific’s Web of Knowledge.

Here’s the notice, for “Hsp90 Interaction with INrf2(Keap1) Mediates Stress-induced Nrf2 Activation,” which is unfortunately a return to the JBC’s opacity: Continue reading University of Maryland researchers notch second retraction

Weekend reads: Self-plagiarism and moral panic; sexism in science; peer review under scrutiny

booksAnother busy week at Retraction Watch, which kicked off with our announcement that we’re hiring a paid intern. Here’s what was happening elsewhere around the web: Continue reading Weekend reads: Self-plagiarism and moral panic; sexism in science; peer review under scrutiny

Ethics training paper retracted because data couldn’t be shared

sci eng ethicsA group of authors at the University of Oklahoma have retracted a 2013 paper on ethics training after the university found that the data they used couldn’t be shared publicly.

Here’s the notice for “Improving Case-Based Ethics Training: How Modeling Behaviors and Forecasting Influence Effectiveness:” Continue reading Ethics training paper retracted because data couldn’t be shared

Former Mount Sinai postdoc faked gene therapy data: ORI

ori logoA former postdoc at the Mount Sinai School of Medicine in New York faked data in four published papers, one submitted manuscript, and four NIH grant applications, according to new findings by the Office of Research Integrity.

We reported on six retractions from Savio Woo’s Mount Sinai lab in 2010, from the Proceedings of the National Academy of Sciences (PNAS), the Journal of the National Cancer Institute, and two each from Human Gene Therapy and Molecular Therapy. The PNAS paper, as we noted then:

claimed to have discovered a possible cure for phenylketonuria, or PKU, in mice—a finding that was cited more than 30 times and trumpeted in the media.

At the time, Mount Sinai said that two of the lab’s postdocs had been dismissed for misconduct. Now, more than three and a half years later, the ORI reports that a former postdoc in that lab, Li Chen: Continue reading Former Mount Sinai postdoc faked gene therapy data: ORI

Wrong cell line leads to retraction of kidney cancer study

plosoneA group of authors in China has retracted their December 2013 paper in PLoS ONE after realizing that they’d been studying the wrong cells.

The paper, “Up-Regulation of pVHL along with Down-Regulation of HIF-1α by NDRG2 Expression Attenuates Proliferation and Invasion in Renal Cancer Cells,” came from Lei Gao, of the Fourth Military Medical University, in Xi’an, and colleagues. It purported to find that:

Continue reading Wrong cell line leads to retraction of kidney cancer study

“With deep regrets we apologize:” Economics paper retracted for plagiarism

econ managementAn economics paper has been retracted after the journal that published it became aware that it contained plagiarism.

Here’s the notice: Continue reading “With deep regrets we apologize:” Economics paper retracted for plagiarism

Retractions appear in case of former Kansas water scientist rebuked for misconduct

groundwaterBack in December, the University of Kansas issued a public censure of a former water researcher who, the school says, engaged in a pattern of plagiarism and other shoddy publishing practices.

Marios Sophocleous, who’d held the position of senior scientist at the Kansas Geological Survey:

Continue reading Retractions appear in case of former Kansas water scientist rebuked for misconduct

Crystal unclear? “Business decision” forces retraction of silicon paper

jcgrowthA group of researchers in Tokyo has lost their 2013 article in the Journal of Crystal Growth over commercial interests — which don’t appear to be their own.

We’ll explain.

The article, “Interactions between planar defects in bulk 3C-SiC,” came from a team consisting of a researcher at Keio University and scientists at two companies, HOYA Corporation, an optics firm, and SICOXS Corporation, which makes semiconductor wafers.

According to the abstract: Continue reading Crystal unclear? “Business decision” forces retraction of silicon paper

Plant paper retracted when new species turns out not to be so new

nordic plantIn December, a group of biologists in Thailand published a paper in the Nordic Journal of Botany heralding the discovery of a new species of plant:

Bauhinia saksuwaniae, a new species from northeastern Thailand is described and illustrated. It appears to be an endemic and endangered species. The new species is obviously distinct from all other species of Thai Bauhinia in having large orbicular persistent bracteoles forming a cup-shape and enclosing a young floral bud.

But then came this retraction: Continue reading Plant paper retracted when new species turns out not to be so new

Scientist found to have falsified data in thesis sues to keep her PhD

org lettersIn August 2012, the authors of “Novel Approach to the Lundurine Alkaloids: Synthesis of the Tetracyclic Core,” a paper in Organic Letters, retracted it:

The authors retract this Organic Letters communication on the basis that the RCM of 24 to give 25 (Scheme 6) is not reproducible; thus, the reduction of 25 to give 26 (Scheme 7) is also not reproducible.

The case was covered in some detail by The Heterocyclist blog, and also by Derek Lowe at In The Pipeline, who called it “an odd retraction.” Lowe recently picked up the story with an update: The first author, Suvi Orr, is suing the University of Texas-Austin, where she earned her PhD and did the work, to stop them from taking away her degree.

The Austin American-Statesman reported last month: Continue reading Scientist found to have falsified data in thesis sues to keep her PhD